• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2-(5H-[1]苯并吡喃并[2,3-b]吡啶-7-基)丙酸(Y-8004)(II)的药理学研究。一般药理作用

[Pharmacological studies of 2-(5H-[1]benzopyrano[2,3-b]pyridin-7-yl) propionic acid (Y-8004) (II). General pharmacological action].

作者信息

Maruyama Y, Kadobe Y, Imamura H

出版信息

Nihon Yakurigaku Zasshi. 1976 May;72(4):403-16. doi: 10.1254/fpj.72.403.

DOI:10.1254/fpj.72.403
PMID:987973
Abstract

This anti-inflammatory agent proved to have a therapeutic margin wider than that of indomethacin. Y-8004 exhibited little effect on the central nervous system, somatic and autonomic nervous system. On the cardiovascular system in dogs, Y-8004 induced a slight transient fall in blood pressure followed by a pressor response, increase in heart rate and coronary vasodilation at a dose of 30 mg/kg given intravenously, but no remarkable change was seen on the electrocardiogram. Y-8004 showed no effect on isolated smooth muscles such as vas deferens, ileum and atria, but inhibited gastrointestinal propulsion at a dose of 100 mg/kg given orally in mice and spontaneous contractions of the pregnant uterus of rats at a concentration of more than 10(-6)M. This agent also decreased urine volume and electrolytes in rats. This property was considered to be common to other acidic nonsteroidal anti-inflammatory agents. On the other hand, in guinea pigs, Y-8004 inhibited the bradykinin-induced bronchoconstriction and the collagen-induced platelet aggregation to a greater extent than did indomethacin. These findings suggest that Y-8004 is an active compound with properties similar to acidic non-steroidal anti-inflammatory agents such as indomethacin.

摘要

这种抗炎药的治疗窗比吲哚美辛更宽。Y - 8004对中枢神经系统、躯体和自主神经系统几乎没有影响。在犬的心血管系统上,静脉注射30mg/kg剂量的Y - 8004会引起血压轻微短暂下降,随后出现升压反应、心率增加和冠状血管舒张,但心电图未见明显变化。Y - 8004对输精管、回肠和心房等离体平滑肌无作用,但在小鼠口服100mg/kg剂量时可抑制胃肠推进,在大鼠妊娠子宫浓度高于10(-6)M时可抑制其自发收缩。该药物还可减少大鼠尿量和电解质。这种特性被认为是其他酸性非甾体抗炎药所共有的。另一方面,在豚鼠中,Y - 8004比吲哚美辛更能抑制缓激肽诱导的支气管收缩和胶原诱导的血小板聚集。这些发现表明Y - 8004是一种活性化合物,其性质与吲哚美辛等酸性非甾体抗炎药相似。

相似文献

1
[Pharmacological studies of 2-(5H-[1]benzopyrano[2,3-b]pyridin-7-yl) propionic acid (Y-8004) (II). General pharmacological action].2-(5H-[1]苯并吡喃并[2,3-b]吡啶-7-基)丙酸(Y-8004)(II)的药理学研究。一般药理作用
Nihon Yakurigaku Zasshi. 1976 May;72(4):403-16. doi: 10.1254/fpj.72.403.
2
General pharmacology of recombinant human basic fibroblast growth factor.重组人碱性成纤维细胞生长因子的一般药理学
Arzneimittelforschung. 1996 Jul;46(7):727-39.
3
[Pharmacological studies of 4-ethoxy-2-methyl-5-morpholino-3(2H)-pyridazinone (M73101). (3). General pharmacological actions (author's transl)].4-乙氧基-2-甲基-5-吗啉基-3(2H)-哒嗪酮(M73101)的药理学研究。(3). 一般药理作用(作者译)
Nihon Yakurigaku Zasshi. 1979 Apr 20;75(3):291-307. doi: 10.1254/fpj.75.291.
4
General pharmacological properties of the new vasodilator flosequinan.新型血管扩张剂氟司喹南的一般药理学特性
Arzneimittelforschung. 1992 Oct;42(10):1200-11.
5
General pharmacology of the new antimuscarinic compound vamicamide.新型抗毒蕈碱化合物瓦米卡胺的一般药理学
Arzneimittelforschung. 1995 Dec;45(12):1274-84.
6
[General pharmacology of T-3761, a new oral quinolone antibacterial agent (2). Effect on the respiratory and cardiovascular systems, autonomic nervous system and other functions].
Jpn J Antibiot. 1995 May;48(5):706-32.
7
General pharmacological properties of the main metabolite of flosequinan.氟司喹南主要代谢产物的一般药理学特性。
Arzneimittelforschung. 1992 Oct;42(10):1212-22.
8
[General pharmacology of T-3262, a new pyridonecarboxylic acid].
Jpn J Antibiot. 1989 Apr;42(4):831-53.
9
Pharmacological studies on timiperone, a new neuroleptic drug Part II: General pharmacological properties.新型抗精神病药物替米哌隆的药理学研究 第二部分:一般药理学特性
Arzneimittelforschung. 1981;31(4):707-15.
10
General pharmacological profile of the novel cholecystokinin-A antagonist loxiglumide.新型胆囊收缩素-A拮抗剂洛西格列胺的一般药理学特性
Arzneimittelforschung. 1997 Dec;47(12):1375-82.